John Militello Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

John Militello is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 51,451 shares of RCKT, which is worth approximately $844,310. The most recent transaction as insider was on Aug 16, 2024, when has been sold 1,064 shares (Common Stock) at a price of $18.5 per share, resulting in proceeds of $19,684. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.5K

3.52% 3M change

823.72% 12M change

Total Value Held $844,310

John Militello Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 16 2024	SELL Open market or private sale	$19,684 $18.5 p/Share	1,064 Reduced 2.03%	51,451 Common Stock
Jul 22 2024	SELL Open market or private sale	$18,692 $23.02 p/Share	812 Reduced 1.52%	52,515 Common Stock
May 16 2024	SELL Open market or private sale	$25,194 $23.35 p/Share	1,079 Reduced 1.98%	53,327 Common Stock
Apr 22 2024	SELL Open market or private sale	$19,050 $22.87 p/Share	833 Reduced 1.51%	54,406 Common Stock
Mar 21 2024	SELL Open market or private sale	$69,969 $28.1 p/Share	2,490 Reduced 4.31%	55,239 Common Stock
Feb 29 2024	SELL Open market or private sale	$298,400 $29.84 p/Share	10,000 Reduced 31.73%	21,517 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	$125,500 $12.55 p/Share	10,000 Added 24.09%	31,517 Common Stock
Feb 16 2024	SELL Open market or private sale	$96,621 $29.84 p/Share	3,238 Reduced 19.7%	13,195 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	8,322 Added 27.89%	21,517 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	6,274 Added 27.63%	16,433 Common Stock
Jan 22 2024	SELL Open market or private sale	$17,353 $27.2 p/Share	638 Reduced 5.91%	10,159 Common Stock
Jan 18 2024	BUY Exercise of conversion of derivative security	-	1,586 Added 12.81%	10,797 Common Stock
Nov 14 2023	BUY Exercise of conversion of derivative security	-	725 Added 7.1%	9,485 Common Stock
Oct 20 2023	SELL Open market or private sale	$9,621 $17.06 p/Share	564 Reduced 6.05%	8,760 Common Stock
Aug 17 2023	SELL Open market or private sale	$4,393 $15.47 p/Share	284 Reduced 4.85%	5,570 Common Stock
Aug 14 2023	BUY Exercise of conversion of derivative security	-	725 Added 8.45%	7,854 Common Stock
Jul 20 2023	SELL Open market or private sale	$10,904 $19.03 p/Share	573 Reduced 7.44%	7,129 Common Stock
Jul 18 2023	BUY Exercise of conversion of derivative security	-	1,586 Added 17.08%	7,702 Common Stock
May 17 2023	SELL Open market or private sale	$5,238 $21.38 p/Share	245 Reduced 3.85%	6,116 Common Stock
May 14 2023	BUY Exercise of conversion of derivative security	-	725 Added 10.23%	6,361 Common Stock
Apr 21 2023	SELL Open market or private sale	$43,678 $18.65 p/Share	2,342 Reduced 29.36%	5,636 Common Stock
Apr 18 2023	BUY Exercise of conversion of derivative security	-	6,364 Added 44.37%	7,978 Common Stock
Feb 17 2023	SELL Open market or private sale	$23,710 $19.06 p/Share	1,244 Reduced 43.53%	1,614 Common Stock
Feb 14 2023	BUY Other acquisition or disposition	-	11,067 Added 16.09%	57,729 Common Stock
Aug 12 2022	BUY Other acquisition or disposition	-	14,310 Added 23.47%	46,662 Common Stock

John Militello

Cranbury, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Value

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

Operation

Value

Type

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Track Activities on RCKT

Account